E-LIB Suche - Ergebnisse für: Lopes De Menezes, Daniel

1

P567: PHASE 1B OMNIVERSE TRIAL: SAFETY AND TOLERABILITY OF ..:

Fleming, Shaun ; Roboz, Gail ; T. Fathi, Amir...
HemaSphere. 7 (2023) S3 - p. e27202d1 , 2023

Link: https://doi.org/10.1097/..

2

P411: LONGITUDINAL CHARACTERIZATION OF MOLECULAR VARIANTS A..:

Lopes De Menezes, Daniel ; Wei, Andrew ; Döhner, Hartmut...
HemaSphere. 7 (2023) S3 - p. e930876b , 2023

Link: https://doi.org/10.1097/..

3

P459: DISEASE MONITORING OF NPM1-MUTANT (MUT) ACUTE MYELOID..:

Lopes De Menezes, Daniel ; Roboz, Gail ; Döhner, Hartmut...
HemaSphere. 7 (2023) S3 - p. e8574862 , 2023

Link: https://doi.org/10.1097/..

4

Prognostic impact of NPM1 and FLT3 mutations in patients wi..:

Döhner, Hartmut ; Wei, Andrew H. ; Roboz, Gail J....
Blood. 140 (2022) 15 - p. 1674-1685 , 2022

Link: https://doi.org/10.1182/..

5

Pharmacokinetics of Bcl-2 antisense oligonucleotide (G3139)..:

Lopes de Menezes, Daniel ; Mayer, Lawrence
Cancer Chemotherapy and Pharmacology. 49 (2002) 1 - p. 57-68 , 2002

Link: https://doi.org/10.1007/..

6

Quantitative fluorescence cytometric analysis of Bcl-2 leve..:

Dragowska, Wieslawa H. ; Lopes de Menezes, Daniel E. ; Sartor, Jason.
Cytometry. 40 (2000) 4 - p. 346-352 , 2000

Link: https://doi.org/10.1002/..

7

Selective targeting of immunoliposomal doxorubicin against ..:

Lopes de Menezes, Daniel E. ; Pilarski, Linda M. ; Belch, Andrew R..
Biochimica et Biophysica Acta (BBA) - Biomembranes. 1466 (2000) 1-2 - p. 205-220 , 2000

Link: https://doi.org/10.1016/..

8

Long-circulating, polyethylene glycol-grafted immunoliposom..:

Zalipsky, Samuel ; Hansen, Christian B. ; Lopes de Menezes, Daniel E..
Journal of Controlled Release. 39 (1996) 2-3 - p. 153-161 , 1996

Link: https://doi.org/10.1016/..

9

Integrated genetic, epigenetic, and immune landscape of TP5..:

Zeidan, Amer M. ; Bewersdorf, Jan Philipp ; Hasle, Vanessa...
Therapeutic Advances in Hematology. 15 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

10

P997: FEDRATINIB IS EFFECTIVE IN RUXOLITINIB-RESISTANT CELL..:

Jeyaraju, Danny ; Hayati, Sheida ; Polonskaia, Ann...
HemaSphere. 7 (2023) S3 - p. e975395e , 2023

Link: https://doi.org/10.1097/..

11

Survival outcomes in patients with acute myeloid leukaemia ..:

Ravandi, Farhad ; Döhner, Hartmut ; Wei, Andrew H....
British Journal of Haematology. 204 (2023) 3 - p. 877-886 , 2023

Link: https://doi.org/10.1111/..

12

Prognostic implications of mono-hit and multi-hit TP53 alte..:

Zeidan, Amer M. ; Bewersdorf, Jan Philipp ; Hasle, Vanessa...
Leukemia. 37 (2022) 1 - p. 240-243 , 2022

Link: https://doi.org/10.1038/..

13

Quantification of azacitidine incorporation into human DNA/..:

Wang, Xiaomin ; Vaes, Wouter H.J. ; van Duijn, Esther...
Journal of Pharmaceutical and Biomedical Analysis. 202 (2021) - p. 114152 , 2021

Link: https://doi.org/10.1016/..

14

P567: PHASE 1B OMNIVERSE TRIAL: SAFETY AND TOLERABILITY OF ..:

Fleming, Shaun ; Roboz, Gail ; T. Fathi, Amir...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428987/. , 2023

Link: http://www.ncbi.nlm.nih...

15

P411: LONGITUDINAL CHARACTERIZATION OF MOLECULAR VARIANTS A..:

Lopes De Menezes, Daniel ; Wei, Andrew ; Döhner, Hartmut...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428725/. , 2023

Link: http://www.ncbi.nlm.nih...